Intercept Pharmaceuticals Inc., is a clinical stage biopharmaceutical company developing therapeutics for the treatment of chronic fibrotic and metabolic diseases.
Current News
  • August 7th, 2008 - Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling ... More »